Patient Profile and Antimicrobial Susceptibility Testing of Clinically Isolates In E. coli

Year : 2024 | Volume :14 | Issue : 01 | Page : 32-47
By

Syed Asra Kirmani

Jasmina Javaid Shah

  1. Student Department of Chemical Microbiology, Rayat Bahra University, Mohali Punjab India
  2. Assistant Professor Department of Allied & Health Sciences, Rayat Bahra University, Mohali Punjab

Abstract

Escherichia coli, commonly known as E. coli, is a prevalent bacterium capable of causing infections in humans. The development of antimicrobial resistance in E. coli poses a significant public health issue. This study aimed to determine the patient profile and antimicrobial susceptibility patterns of clinically isolated E. coli. A retrospective study was carried out on E. coli samples collected from clinical specimens within a hospital environment. Patient profiles, including age, gender, and underlying medical conditions, were recorded. Standard methods were employed to conduct antimicrobial susceptibility testing on the E. coli isolates, with interpretation of the results based on clinical breakpoints advised by the Clinical and Laboratory Standards Institute. The patient profile and antimicrobial susceptibility patterns of E. coli isolates were analyzed and presented. Descriptive statistics showed that the majority of patients were female and had urinary tract infections. Antimicrobial susceptibility testing revealed that E. coli isolates were highly resistant to ampicillin and sulfamethoxazole/trimethoprim, but susceptible to carba penems and amino glycosides. Correlations of notable significance were identified between age and antimicrobial resistance. These findings can inform the development of effective treatment strategies and antimicrobial stewardship programs to combat the spread of antimicrobial resistance in E. coli. The result of antibiotic susceptibility testing revealed varying patterns of resistance among the Escherichia coli isolates. Some strains exhibited a high degree of susceptibility to multiple antibiotics, while others demonstrated resistance, particularly to certain classes of antibiotics. Data analysis highlighted notable trends and correlations between specific antibiotics and resistance patterns. These findings hold crucial implications for informing suitable treatment approaches for Escherichia coli infections. Understanding the antibiotic susceptibility pattern of clinically isolated strains can aid healthcare providers in selecting effective antimicrobial therapies and minimizing the spread of resistant strains.

Keywords: Escherichia coli, Antibiotics, Antimicrobial susceptibility test, Model Organism, Culture media

[This article belongs to Research & Reviews: A Journal of Microbiology & Virology(rrjomv)]

How to cite this article: Syed Asra Kirmani, Jasmina Javaid Shah. Patient Profile and Antimicrobial Susceptibility Testing of Clinically Isolates In E. coli. Research & Reviews: A Journal of Microbiology & Virology. 2024; 14(01):32-47.
How to cite this URL: Syed Asra Kirmani, Jasmina Javaid Shah. Patient Profile and Antimicrobial Susceptibility Testing of Clinically Isolates In E. coli. Research & Reviews: A Journal of Microbiology & Virology. 2024; 14(01):32-47. Available from: https://journals.stmjournals.com/rrjomv/article=2024/view=145575





Browse Figures

References

  1. Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., Ouellette, M., Outterson, K., Patel, J., Cavaleri, M., Cox, E. M., Houchens, C. R., Grayson, M. L., Hansen, P., Singh, N., Theuretzbacher, U., … WHO Pathogens Priority List Working Group (2018). Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet. Infectious diseases, 18(3), 318–327. https://doi.org/10.1016/S1473–3099(17)30753–3
  2. Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, Zhang F, Wang R, Klompas M, CDC Prevention Epicenters Program. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA network open. 2020 Apr 1;3(4):e202899-.
  3. Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. Journal of clinical microbiology. 2020 Feb 24;58(3):10–128.
  4. Tadesse DA, Zhao S, Tong E, Ayers S, Singh A, Bartholomew MJ, McDermott PF. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerging infectious diseases. 2012 May;18(5):741.
  5. Umair M, Walsh TR, Mohsin M. A systematic review and meta-analysis of carbapenem resistance and its possible treatment options with focus on clinical Enterobacteriaceae: Thirty years of development in Pakistan. Heliyon. 2024 Mar 17.
  6. Wardoyo, Eustachius Hagni et al. “Antibiotics susceptibility of Escherichia coliisolates from clinical specimens before and during COVID-19 pandemic.” Iranian journal of microbiology 13,2 (2021): 156–160. doi:10.18502/ijm.v13i2.5974
  7. Kibret, M., & Abera, B. (2011). Antimicrobial susceptibility patterns of coli from clinical sources in northeast Ethiopia. African health sciences, 11 Suppl 1(Suppl 1), S40–S45. https://doi.org/10.4314/ahs.v11i3.70069
  8. Hlaváček, A., Křivánková, J., Brožková, H., Weisová, J., Pizúrová, N., & Foret, F. (2022). Absolute Counting Method with Multiplexing Capability for Estimating the Number Concentration of Nanoparticles Using Anisotropically Collapsed Gels. Analytical chemistry, 94(41), 14340–14348. https://doi.org/10.1021/acs.analchem.2c02989
  9. Rao R P, Sharma S, Mehrotra T, Das R, Kumar R, Singh R, Roy I, Basu T. Rapid electrochemical monitoring of bacterial respiration for Gram-positive and Gram-negative microbes: potential application in antimicrobial susceptibility testing. Analytical chemistry. 2020 Feb 13;92(6):4266–74.
  10. Wagenlehner FM, Naber KG, Weidner W. Rational antibiotic therapy of urinary tract infections. Medizinische Monatsschrift fur Pharmazeuten. 2008 Oct 1;31(10):385–90.
  11. De Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N. Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. Medical science monitor. 2007 May 31;13(6):BR136–44.
  12. Kashef N, Djavid GE, Shahbazi S. Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran, Iran. The Journal of Infection in Developing Countries. 2010 Jan 20;4(04):202–6.
  13. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagnostic microbiology and infectious disease. 2004 Sep 1;50(1):59–69.
  14. Gebre-Sealsssie S. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia. Ethiopian medical journal. 2007 Oct 1;45(4):363–70.

Regular Issue Subscription Original Research
Volume 14
Issue 01
Received March 26, 2024
Accepted April 14, 2024
Published May 8, 2024